Smartwatch data is rich but clinical integration is weak: Why only 6% of doctors truly use wearable devices?

Smartwatches are becoming ubiquitous, and the health data collected by devices like the Apple Watch Series 10 and Oura Ring 5 is increasingly abundant. However, according to the latest international physician survey released by the American Medical Association (AMA), this data has not been effectively translated into clinical practice. Among the 2,222 doctors surveyed, about 77% of U.S. physicians believe that using wearable data offers "clinical advantages," but only 6% have actually integrated wearable device data into their workflows—and this was the best figure among the six countries surveyed.

Abundant Data, But Missing Clinical Pathways

"We have all this available data, but it's not actually actionable because we don't have ways to bring it into the clinical workflow," Dr. John Whyte, CEO of the AMA, pointed out in an interview with Healthcare Dive. The survey, covering the United States, Canada, France, Germany, Spain, and the United Kingdom, revealed barriers at multiple levels.

First, data integration is not straightforward. While wearable device manufacturers generally allow users to send health data to healthcare providers, seamlessly incorporating this data into electronic health record (EHR) systems is often challenging. Interoperability standards between different systems are lacking, requiring physicians to manually parse data from various sources—time-consuming and error-prone.

Second, insufficient clinical validation lies at the heart of the trust gap. Most smartwatch health features are designed as screening tools rather than diagnostic tools. The Apple Watch Series 4 garnered significant attention for its FDA-cleared ECG function, but that does not mean it can replace a traditional electrocardiogram monitor. Apple and other companies obtain authorizations or certifications through various pathways, some of which are not as rigorous as those for genuine medical devices. Whyte emphasized that physicians need to confirm whether the wearable data they see is reliable, and the lack of extensive evidence from clinical testing leaves many doctors cautious.

Reimbursement Issues Become a Key Driver

Beyond data accessibility and validity, the AMA survey also found that doctors lack clear pathways for having the time spent reviewing wearable data covered by insurance. This is especially true in the United States: "CPT codes for remote patient monitoring require the use of FDA-cleared devices under a clinician-directed care plan," the AMA noted. These codes do not cover consumer wearable devices, even if they have FDA-cleared features.

Reimbursement is not the only factor determining whether doctors use wearable data, but the survey did find that in countries like Germany, where clearer reimbursement pathways exist, the integration of wearables is higher. This suggests that policy design can significantly influence the pace of clinical adoption of new technologies.

Industry Impact and Future DirectionsThis situation holds significant implications for the entire medical technology industry. For wearable device manufacturers, simply adding more sensors and features may not be enough to drive clinical adoption; they need to actively collaborate with healthcare systems to ensure that data can be trusted, integrated, and interpreted by doctors. Companies such as Apple, Samsung, and Google are continuously launching more powerful health monitoring devices—new-generation smartwatches are expected to debut within the next one to two months—but without systemic changes, they will find it difficult to fundamentally alter how doctors diagnose and treat patients.

Hospitals and medical institutions face the challenge of balancing innovation with safety. Some leading healthcare systems have already begun piloting wearable device projects, such as integrating Apple Health Records with EHR. However, they still need to overcome obstacles related to insurance reimbursement and regulatory boundaries. In the future, as demand for remote patient monitoring and digital health management rises, policymakers are expected to gradually update CPT codes to cover the use of consumer-grade wearables in clinical pathways.